本平台为互联网非涉密平台,严禁处理、传输国家秘密、工作秘密或敏感信息

基于代谢组学及网络药理学的药食同源复方降脂活性成分与作用靶点比较
DOI:
CSTR:
作者:
作者单位:

1.沈阳农业大学食品学院;2.辽宁中医药大学

作者简介:

通讯作者:

中图分类号:

基金项目:

辽宁省科技厅重点研发计划项目


Study on Active Components and Target Effects of Compound Lipid-Lowering Agents with Food-Drug Homology Based on Metabolomics and Network Pharmacology
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为研究基于药食同源复方的体外抗氧化活性及其降脂、降糖功效,本研究通过网络药理学分析和体外酶抑制试验,挖掘复方提取物调控糖脂代谢、改善机体病变的潜在作用通路。分析显示,莲肉、人参、芡实、扁豆复方原料干预调控的核心靶点,主要富集并作用于2型糖尿病、高脂血症相关的糖脂代谢紊乱通路。进一步测定四种药食同源原料水提液的DPPH、ABTS体外抗氧化能力,以及胰脂肪酶、α-淀粉酶、α-葡萄糖苷酶抑制活性,并开展活性指标间的相关性分析。结果表明,复方DPPH清除能力复方混合组(0.98±0.01)mg VCE/g DW。复方的活性显著高于芡实、人参、扁豆单味中药;相较于各单味中药,复方ABTS自由基清除能力最优,活力为(2.63±0.04)mg VCE/g DW;酶抑制活性方面,复方混合组呈现出显著的协同增效的作用,其中α-葡萄糖苷酶抑制活性为(0.04±0.002)mg Acarbose/g DW,脂肪酶抑制活性为(0.047±0.006)mg Orlistat/g DW。复方α-淀粉酶抑制活性与人参、扁豆相当。综上,莲肉、人参、芡实、扁豆在降糖、降脂、改善糖脂代谢方面表现出良好的应用前景,为开发基于天然产物的降糖降脂功能性产品提供了科学依据。

    Abstract:

    To investigate the in vitro antioxidant activity as well as hypoglycemic and hypolipidemic effects of a medicinal and edible homologous compound formula, network pharmacology analysis and in vitro enzyme inhibition assays were performed in this study to explore the potential signaling pathways through which the compound extract regulates glucose and lipid metabolism and alleviates organic lesions.The analysis revealed that the core targets modulated by the formula consisting of lotus seed,ginseng, Euryale ferox seed and hyacinth bean were mainly enriched in pathways related to glucose and lipid metabolism disorders in type 2 diabetes mellitus and hyperlipidemia. Furthermore, the in vitro antioxidant capacities (DPPH and ABTS radical scavenging activities) of aqueous extracts from the four medicinal and edible raw materials, together with their inhibitory activities against???ancreatic lipase, α-amylase and α-glucosidase, were determined, followed by correlation analysis among all activity indicators. The results demonstrated that the DPPH radical scavenging capacity of the combined compound group reached (0.98 ± 0.01) mg VcE/g DW, which was significantly higher than that of single extracts of Euryale ferox seed, ginseng and hyacinth bean. The compound also exhibited the optimal ABTS radical scavenging activity among all single ingredients, with a value of (2.63 ± 0.04) mg VcE/g DW. In terms of enzyme inhibitory activity, the compound mixture showed remarkable synergistic effects: its α-glucosidase inhibitory activity was (0.04 ± 0.002) mg Acarbose/g DW, and pancreatic lipase inhibitory activity was (0.047 ± 0.006) mg Orlistat/g DW. Meanwhile, the α-amylase inhibitory activity of the compound was comparable to that of ginseng and hyacinth bean.In conclusion, the combination of lotus seed, ginseng, Euryale ferox seed and hyacinth bean possesses promising application prospects in hypoglycemia, lipid reduction and amelioration of glucose-lipid metabolism disorders. This study provides scientific evidence for the development of natural functional foods with hypoglycemic and hypolipidemic properties.

    参考文献
    相似文献
    引证文献
引用本文
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-07-14
  • 最后修改日期:2026-09-24
  • 录用日期:2026-09-24
  • 在线发布日期:
  • 出版日期:
文章二维码